N	Concordance
1	 with the increasing cumulative dose of ifosfamide (32-126 g/m2), urinary retino
2	llelic variants in cyclophosphamide and ifosfamide activation as an initial atte
3	 schedule-dependent effect of high-dose ifosfamide against soft-tissue sarcomas.
4	 by chemotherapy, comprising etoposide, ifosfamide and carboplatin. A response w
5	 therapy with doxorubicin and high dose ifosfamide can be administered safely wi
6	investigates increasingly high doses of ifosfamide combined with full dose doxor
7	ose escalation in the administration of ifosfamide (IFX) on an outpatient schedu
8	has a phase II trial of doxorubicin and ifosfamide in patients with advanced syn
9	4 and 8 h later. To simplify outpatient ifosfamide therapy, we gave the second a